출판사: Visiongain / 출판일: 2011-05-10 / 페이지: 137 / 가격: Single User PDF;＄2,418 Global Site License;＄11,254
보고서 세부사항 상업적인 기회를 어떻게 발견할 것인가? 줄기 세포 시장 다가오는 10년동안 어떻게 개발될 것인가? 우리의 새로운 보고서는 당신에게 2011년부터 2021년까지 급 부상하는 산업과 시장의 수익 잠재성을 보여준다. 이 보고서는 치료 응용에서 줄기세포를 다룬다: 응용 과학, 제품과 서비스. 당신은 사건, 기회 및 산업 활동 형성을 평가할 것이다. 우리는 당신의 시간을 절약하고 우리의 연구, 분석과 논의를 통해 당신의 결정을 돕기를 목표로 한다. 우리의 새로운 연구는 당신에게 2021년까지 전세계, 하위 시장 및 제품 단계에 관한 수익 측면을 보여준다. 어떤 행동이 2011년부터 2021년까지 시장을 확대 시킬 것인가? 우리의 작업은 당신에게 줄기 세포 산업과 시장을 이해하는데 도움을 준다. 많은 수의 줄기 세포 치료법은 언제 착수 될 것인가? 어떤 질병 영역에서 줄기 세포 치료법은 가장 큰 잠재력을 지닐 것인가? 우리는 어떤 시장이 2011년 이래로 연구, 제품 개발 및 영업에 관한 최상의 기회를 제공할 것인지 당신에게 보여줄 것이다. 무엇이 줄기 세포 치료법 개발에서 가장 중대한 운영요소 및 억제요소인가? 치료를 넘어서 줄기 세포를 어떻게 다른 분야에 사용할 것인가? 우리들의 보고서는 당신이 원하는 데이터와 해답을 제공한다. 우리는 2011년까지 줄기 세포 산업과 시장의 강점, 약점, 경향 및 수익 기회를 평가하기 위해 당신을 돕는다. 당신은 줄기세포 응용과학이 어디로 향하는지 볼 것이다. 우리들의 보고서는 당신에게 연구, 수치, 미팅 및 발표 데이터, 분석 및 의견을 제공한다. 당신의 작업을 돕기 위한 산업과 시장 분석
우리들의 보고서는 당신에게 수익 예측, 성장률 및 시장 점유율을 제공한다. 우리는 또한 조사를 통한 의견을 통하여 우리는 66테이블 및 차트 그리고 연구 인터뷰를 포함한다(첨부 리스트에서 보여진). 특히, 우리는 인체에 사용하는 만능 줄기 세포 및 다능 줄기 세포 연구와 응용프로그램을 다룬다. 줄기 세포 응용과학: 세계 시장 전망 2011-2021은 당신에게 수익 경향, 기회, 그리고 도전을 보여준다. 목차 1. 개요 1.1 연구 총람 1.2 챕터 세분화 1.3 연구 및 분석 방법 2. 줄기 세포 응용과학 소개 2.1 줄기 세포란? 2.2 줄기 세포를 어떻게 분류할 것인가? 2.3 줄기 세포는 어디서 오는 것인가? 3. 세계 줄기 세포 시장 2011-2021 3.1 줄기 세포 시장 정의 3.2 줄기 세포 시장 2011-2021에서 성장 3.3 줄기 세포 치료법 3.4 골 수 이식 3.5 줄기 세포 서비스 3.6 혈액 은행 4. 줄기 세포 시장을 운영하는 기업 4.1 줄기 세포 치료법을 개발하는 선두 기업 4.2 줄기 세포 서비스를 제공하는 몇몇 기업 4.3 선별된 개인 코드 혈액 은행 5. 줄기 세포 응용과학 시장 2011-2021에 영향을 미치는 화제
5.1 줄기 세포 시장 2011-2021에 관한 SWOT 차트 5.2 강점 5.3 약점 5.4 기회 5.5 위협 6. 줄기 세포 치료법 2011-2021에 관한 치료 응용 프로그램 6.1 단기 징후 6.2 심혈관 질병 6.3 중추 신경계 질병 6.4 장기 성장 7. 줄기 세포 시장 2011-2021의 지역별 분석 8. 연구 인터뷰 9. 결론 보고서 문의
Report Details
- how you can discover the commercial opportunities there
How will the stem cells market develop this decade? Our new report shows you that emerging industry and market's revenue potential from 2011 to 2021.
This report covers stem cells in therapeutic applications: technologies, products and services. You will assess events, opportunities and activities shaping that industry. We aim to save you time and aid your decisions through our research, analysis and discussions.
Our new study shows you revenue prospects for stem cells at total world, submarket and product levels to 2021. What activities will expand that market from 2011 to 2021? Our work helps you to understand the stem cells industry and market.
When will significant numbers of stem cell therapies be launched? Which disease areas hold the greatest potential for stem cell therapies? We show you which markets will provide the best opportunities for research, product development and business from 2011 onwards.
What are the most crucial drivers and restraints in the development of stem cell therapies? How significant are other uses for stem cells, beyond therapy? Our report provides data and answers you need.
We help you to assess the stem cell industry and market's strengths, weaknesses, trends and revenue opportunities to 2021. You will see where stem cell technologies are heading.
Our new report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. To get that information please respond now.
Industry and market analysis to help your work - so you won't be left behind
Our report gives you revenue forecasts, growth rates and market shares. We also provide a SWOT/STEP review and analysis of companies, technologies and regulations, as well as opinions from our survey.
We include 66 tables and charts and a research interview (shown in the accompanying lists). In particular, we cover research and applications involving pluripotent and multipotent stem cells for human use.
Stem Cell Technologies: World Market Outlook 2011-2021 shows you revenue trends, opportunities and challenges
Our report gives you the following advantages:
• You will receive hard data for the stem cells industry and market - especially our revenue forecasts to 2021
• You will discover revenue predictions for the overall market from 2011 to 2021
• You will receive market forecasts for the main subsectors - stem cell therapies, stem cell services, cord blood banking and bone marrow transplants
• You will discover revenue prospects to 2021 for the leading stem cell product
• You will find out which disease areas are receiving the most attention from researchers and how soon treatments can be launched
• You will receive analysis of the uses of stem cells and discussion of the commercial prospects for their use beyond therapy
• You will review stem cell regulations, research and related activities in the US, Japan, Germany, France, Spain, the UK, Italy, China, India, Israel and South Korea
• You will identify the leading companies in stem cell therapies, stem cell services and cord blood banking - we discuss the activities of over 40 companies there
• You will investigate competition and opportunities influencing the industry and market • You will see what will stimulate and restrain the industry and market from 2011
• You will analyse opportunities and challenges for established companies and those seeking to enter the stem cells market from 2011
• You will review the technologies in development, assessing stem cell R&D potential • You will view opinion from our industry survey.
That mix of quantitative and qualitative market analysis sets our report apart. Our analysis helps you to stay ahead in commercial knowledge for stem cell technologies.
Table of Contents
1. Executive Summary 1.1 Overview of Findings 1.2 Chapter Breakdown
1.3 Research and Analysis Methods
1.3.1 Speculative Aspects of Assessing the Stem Cell Field 2. Introduction to Stem Cell Technologies
2.1 What Are Stem Cells?
2.2 How Are Stem Cells Classified? 2.2.1 Totipotency
2.2.2 Pluripotency 2.2.3 Multipotency 2.2.4 Oligopotency 2.2.5 Unipotency
2.3 Where Do Stem Cells Come From? 2.3.1 Embryonic Stem Cells
2.3.1.1 Abortion Debates, IVF and Embryonic Stem Cells 2.3.1.2 Harvesting Human Eggs
2.3.2 Adult Stem Cells
2.3.3 Umbilical Cord Blood Stem Cells 3. The Global Stem Cells Market 2011-2021 3.1 Defining the Stem Cells Market
3.2 Growth in the Stem Cells Market 2011-2021 3.3 Stem Cell Therapies
3.3.1 Stem Cell Therapies Market Forecast 2011-2021 3.3.2 Stem Cells and Bone Regeneration
3.3.2.1 Osteocel Plus (NuVasive)
3.3.2.2 Osteocel Plus Sales Forecast 2011-2021 3.3.2.3 Other Orthopaedic Stem Cell Products 3.3.3 Stem Cells and Regenerative Medicine 3.3.4 Stem Cell Cosmetics
3.3.5 Unregulated Stem Cell Therapies 3.4 Bone Marrow Transplants
3.4.1 Graft-versus-Host Disease and Host-versus-Graft Disease 3.4.2 Bone Marrow Transplants and Medicare Coverage 3.4.3 Private Bone Marrow Transplant Forecast 2011-2021 3.4.4 Peripheral Blood Stem Cell Transplants
3.4.5 Cord Blood Stem Cell Transplants 3.5 Stem Cell Services
3.5.1 Disease Modelling 3.5.2 Toxicity Screening
3.5.3 Stem Cell Services Market Forecast 2011-2021 3.6 Blood Banking
3.6.1 Private vs. Public Blood Banks
3.6.2 Arguments For and Against Cord Blood Banking
3.6.3 Private Cord Blood Banking Market Forecast 2011-2021 4. Companies Driving the Stem Cells Market
4.1 Leading Companies Developing Stem Cell Therapies 4.1.1 Aastrom Biosciences
4.1.2 Advanced Cell Technology 4.1.3 AmStem
4.1.4 Athersys 4.1.5 BioHeart
4.1.6 BrainStorm Cell Therapeutics 4.1.7 Cytori Therapeutics
4.1.8 Gamida Cell 4.1.9 Geron
4.1.9.1 Geron and GE Healthcare 4.1.10 MediStem Laboratories 4.1.11 Mesoblast 4.1.12 Neostem 4.1.13 Neuralstem 4.1.14 Opexa Therapeutics 4.1.14.1 Tovaxin 4.1.15 Osiris Therapeutics 4.1.15.1 Prochymal 4.1.15.2 Chondrogen 4.1.16 Pluristem Therapeutics 4.1.17 Reliance Life Sciences 4.1.18 ReNeuron
4.1.19 StemCells
4.1.20 TCA Cellular Therapy
4.2 Some Companies Offering Stem Cell Services 4.2.1 Axiogenesis
4.2.2 BioTime
4.2.2.1 CellCure Neurosciences 4.2.3 CellCyte Genetics
4.2.4 Cellular Dynamics International 4.2.5 International Stem Cell Corp 4.2.6 MultiCell Technologies 4.2.7 Regenetech
4.2.8 Stem Cell Innovations 4.2.9 Stemgent
4.2.10 Thermo Fisher Scientific/HyClone 4.2.11 ViaCyte
4.2.12 Vitro Biopharma
4.3 Selected Private Cord Blood Banks 4.3.1 Biogenea-Cellgenea
4.3.3 Cord Blood America 4.3.4 Cryo-Cell International 4.3.5 Cryo-Save 4.3.6 LifebankUSA 4.3.7 Thermogenesis 4.3.8 ViaCord
5. Issues Affecting the Stem Cell Technologies Market 2011-2021 5.1 SWOT Chart for the Stem Cells Market 2011-2021
5.2 Strengths
5.2.1 Stem Cell Therapies Already Have a Number of Applications 5.2.2 Stem Cells Have Vast Therapeutic Potential
5.2.3 Stem Cells Have Uses Beyond Therapy 5.2.4 Strength in Numbers
5.2.5 Strong Government Support for Stem Cells 5.3 Weaknesses
5.3.1 The Research Field is Fragmented
5.3.2 A Complex Intellectual Property Environment
5.3.3 Research Relies Too Heavily on Government Funding 5.3.4 Difficulties in Scaling Up
5.3.5 Neither Autologous nor Allogeneic Therapies Are Perfect Yet 5.3.5.1 Autologous Therapies
5.3.5.2 Allogeneic Therapies
5.3.5.3 Incompatibility with the Existing Pharmaceutical Model? 5.4 Opportunities
5.4.1 Leading Pharma Companies Investing in Stem Cell Research 5.4.2 The Potential of iPSCs
5.4.2.1 Transdifferentiation
5.4.3 Philanthropy May Prove a Good Source of Funding 5.4.4 Asia Offers Dynamic Opportunities
5.4.4.1 South Korea 5.4.4.2 Israel
5.4.5 The First New Therapies Launched Will Drive Market Growth 5.5 Threats
5.5.1 Some Companies Will Fail
5.5.1.1 Case Study: Garnet BioTherapeutics 5.5.2 Maintaining Public Support is Vital but Difficult 5.5.3 Difficulties with Animal Models
5.5.4 There Remains Uncertainty in the Future Pathway of US Research 5.5.5 Rapid Progress Makes Certain Discoveries Obsolete
6. Therapeutic Applications for Stem Cell Therapies 2011-2021 6.1 Near-Term Indications
6.1.1 Cancer
6.1.1.1 Cancer Stem Cells 6.1.2 Immune Disorders 6.1.3 Eye Diseases 6.1.4 Orthopaedics 6.1.5 Diabetes
6.2 Cardiovascular Diseases
6.3 Central Nervous System (CNS) Diseases 6.3.1 Amyotrophic Lateral Sclerosis (ALS) 6.3.2 Multiple Sclerosis
6.3.2.1 Pelizaeus-Merzbacher Disease (PMD) 6.3.3 Alzheimer's Disease
6.3.4 Cerebral Palsy 6.3.5 Parkinson's Disease 6.3.6 Spinal Cord Injury 6.4 Growing Organs
7. Regional Analysis of the Stem Cells Market 2011-2021 7.1 Global Spread of Stem Cell Research
7.2 The United States
7.2.1 US Market Drivers and Restraints, 2011-2021 7.2.2 California Institute of Regenerative Medicine (CIRM) 7.3 Japan
7.3.1 Commercial Aspects of Stem Cells in Japan 7.4 Europe 7.4.1 The UK 7.4.2 Spain 7.4.3 Germany 7.4.4 France 7.4.5 Italy 7.5 China 7.6 India 8. Research Interview
8.1 Yael Margolin, President and CEO, Gamida Cell 8.1.1 Challenges in Developing Stem Cell Therapies 8.1.2 Israel's Strength in Stem Cell Research 8.1.3 Public Perception of Stem Cell Therapies
8.1.4 Therapeutic Targets and Gamida Cell's Stem Cell Therapies 8.1.5 Umbilical Cord Blood Stem Cells
9. Conclusions
9.1The Stem Cells Market is Currently Small
9.2 Market Growth Will be Dependent on Stem Cell Therapies
9.3 Induced Pluripotent Stem Cells Represent a Strong Market Opportunity 9.4 Stem Cell Therapies Will be Used in Many Disease Areas
9.5 Concluding Remarks
List of Tables
Table 1.1 Currency Exchange Rates, 2009-2010 Table 2.1 Potency and Source of Stem Cells
Table 2.2 Germ Layers and Their Associated Types of Cells and Organs Table 3.1 Global Stem Cell Market, 2010
Table 3.2 Global Stem Cells Market: Forecast, 2010-2021
Table 3.3 Global Stem Cells Market: Drivers and Restraints, 2011-2021 Table 3.4 Selected Uses for Stem Cells Therapies, 2011
Table 3.5 Stem Cell Therapies Market: Drivers and Restraints, 2011-2021 Table 3.6 Osteocel Plus Sales Forecast, 2010-2021
Table 3.7 Companies Not Considered Part of the Stem Cell Market in this Report Table 3.8 Sources of Stem Cells for Bone Marrow Transplants
Table 3.9 Medicare Coverage for Bone Marrow Transplants, 2011
Table 3.10 Bone Marrow Transplants Market: Drivers and Restraints, 2011-2021 Table 3.11 Stem Cell Services Market: Drivers and Restraints, 2011-2021 Table 3.12 Costs of Various Private Cord Blood Banks Worldwide, 2011 Table 3.13 Cord Blood Banking Market: Drivers and Restraints, 2011-2021
Table 4.1 Selected Stem Cell Therapy Companies and Their Leading Products, 2011 Table 4.2 Histostem's Leading Clinical Investigations, 2011
Table 4.3 MultiStem Pipeline, 2011
Table 4.4 Gamida Cell's Stem Cell Therapy Pipeline, 2011 Table 4.5 Geron's Stem Cell Therapy Pipeline, 2011 Table 4.6 Clinical Progress of GRN-1632, 2011
Table 4.7 Osiris Therapeutics Stem Cell Pipeline, December 2010 Table 4.8 TCA Cellular Therapy Clinical Progress, 2011
Table 4.9 Selected Stem Cell Services Companies, 2011 Table 4.10 Selected Private Cord Blood Banks, 2011
Table 4.11 China Cord Blood Corp Revenue and Subscribers, 2009-2010 Table 4.12 Cryo-Cell International Revenue, 2009-2010
Table 4.13 Cryo-Save Revenue and Operating Profit, 2009-2010 Table 4.14 Cryo-Save Revenue by Region, 2010
Table 5.1 SWOT Analysis of the Market, 2011-2021
Table 5.2 NIH Human Stem Cell Research Funding, 2002-2010 Table 6.1 Selected Examples of Stem Cell Research, 2010-2011 Table 6.2 Stem Cell Clinical Trials by Indication, 2011
Table 6.3 Neurodegenerative Diseases: Stem Cell Clinical Trials by Indication, 2011 Table 7.1 Stem Cell Clinical Trials by Country, 2011
Table 7.2 NIH Stem Cell Research Funding, 2002-2010 Table 7.3 CIRM Funding by Disease, 2004-2011
Table 7.4 Indian Stem Cell Clinical Trials Conducted, 2011
Table 9.1 Stem Cells Market Value and Market Shares, 2010, 2016 and 2021
List of Figures
Figure 2.1 The Early History of Stem Cell Discovery and Development Figure 3.1 Global Stem Cell Market, 2010
Figure 3.2 Global Stem Cells Market Forecast, 2010-2021 Figure 3.3 Stem Cell Therapies Market Forecast, 2010-2021 Figure 3.4 Osteocel Plus Sales Forecast, 2010-2021
Figure 3.5 Private Bone Marrow Transplant Market Forecast, 2011-2021 Figure 3.6 Stem Cell Services Market Forecast, 2010-2021
Figure 3.7 Twenty Year Storage Costs at Various Private Cord Blood Banks Worldwide, 2011 Figure 3.8 Cord Blood Banking Market Forecast, 2010-2021
Figure 4.1 MultiStem Key Events, 2006-2011
Figure 4.2 China Cord Blood Corp Revenue and Subscribers, 2009-2010 Figure 4.3 Cryo-Cell International Revenue, 2009-2010
Figure 4.4 Cryo-Save Revenue and Operating Profit, 2009-2010 Figure 4.5 Cryo-Save Revenue by Region, 2010
Figure 5.1 NIH Human Stem Cell Research Funding, 2002-2010 Figure 5.2 Pfizer's Stem Cell Collaborations, 2008-2011 Figure 6.1 Stem Cell Clinical Trials for Cancer by Phase, 2011
Figure 6.2 Neurodegenerative Diseases: Stem Cell Clinical Trials by Indication, 2011 Figure 6.3 Five Stages of Parkinson's Disease
Figure 7.1 Stem Cell Clinical Trials by Country, 2011 Figure 7.2 NIH Stem Cell Research Funding, 2002-2010
Figure 7.3 Key Events in the US Federal Funding of hESC Research Lawsuit, 2009-2010 Figure 7.4 CIRM Funding by Disease, 2004-2011
Figure 7.5 Example of the UK Stem Cell Therapy Regulatory Pathway, 2011 Figure 9.1 Stem Cells Market by Sector, 2016
Figure 9.2 Stem Cells Market by Sector, 2021
